bpc 157 human clinical trials evidence review 2024 What Orthopedic Surgeons Should Know About Therapeutic Peptides The “Wolverine” Drug – Ortho

Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded

Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders

For injury treatment, continuous use through complete healing (up to 12 weeks) is reasonable, followed by a break

Mechanism of Action BPC-157 works through several interconnected pathways

In reality, they are complementary